A
ABUS
Arbutus Biopharm
4.150
-0.150-3.49%After Hours: 4.170 +0.020 +0.48%19:30 04/10 EDT
OPEN/PREV CLOSE4.310/4.300
TODAY RANGE4.130-4.330
VOL2.67M
MARKET CAP811.23M
52 WEEK RANGE2.705-5.10
AVG VOL (3M)2.24M
% TURNOVER1.37%
TURNOVER--
P/E (TTM)-23.7414
% RANGE4.65%
EPS(TTM)-0.1748
P/E(FORWARD)-59.2011
P/B10.44
BVPS0.3977
DIVIDEND--
P/S56.77
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP636.59M
SHARES OUTSTANDING195.48M
NEXT EARNINGS05/12-05/18
FREE FLOAT153.40M
LOT SIZE1
EX-DATE11/04/2010
News
Press Releases
Financial Reports
Profile
Simply Wall St·03/23 22:13
Arbutus Biopharma (ABUS) Q3 Loss And Revenue Drop Challenge Bullish Profitability Narratives
TipRanks·03/23 12:11
Arbutus Boosted by $2.25 Billion LNP Settlement and Hepatitis B Trial Progress
Dow Jones·03/23 11:31
*Arbutus Biopharma 2025 Rev $14.1M >ABUS
Reuters·03/05 11:03
Moderna Settles Arbutus Genevant Patent Litigation for $950 Million
NASDAQ·03/04 20:27
Notable Wednesday Option Activity: GTLB, ABUS, TTWO
TipRanks·03/04 16:56
Midday Fly By: Stocks climb as oil prices pull back
TipRanks·03/04 16:20
Morning News Wrap-Up 3/4/26: Wednesday’s Biggest Stock Market Stories!
Seeking Alpha·03/04 16:05
Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom
TipRanks·03/04 14:40
Unusually active option classes on open March 4th
Seeking Alpha·03/04 14:18
Moderna gains as Arbutus/ Genevant settlement removes major financial risk
Same Industry
Name/Symbol
Change%
Price